Company Profile

Conformis, Inc. is a medical technology company. The Company is engaged in the development, manufacturing, and sales of patient-specific products and instrumentation that are individually sized and shaped to fit each patient's various knee and hip anatomy. The Company offers knee replacement products and knee replacement products. The Company's product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum Services Program, as well as data-informed, standardized solutions that combine many benefits of personalization with an off-the-shelf system. Its sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. The Company owns or in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

Employees

295

Sector

Medical Equipment, Supplies & Distribution

More about the company

23-09-05	Conformis, Inc. Announces Board Changes	CI
23-09-05	Conformis, Inc.(NasdaqCM:CFMS) dropped from NASDAQ Composite Index	CI
23-09-04	Restor3D, Inc. completed the acquisition of Conformis, Inc. from shareholders.	CI
23-09-01	Conformis, Inc.(NasdaqCM:CFMS) dropped from S&P TMI Index	CI
23-08-02	Conformis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-02	Earnings Flash (CFMS) CONFORMIS Posts Q2 Revenue $13M	MT
23-06-23	Top Midday Gainers	MT
23-06-23	Global markets live: 3M Company, Meta, Moderna, Carmax, Shell...
23-06-23	It just won't go away
23-06-23	Wall Street Set to Open Lower Ahead of June's Flash PMI; Oil Prices Drop Sharply	MT
23-06-23	US Futures Trend Lower Premarket Friday Ahead of June's Flash PMI	MT
23-06-23	Top Premarket Gainers	MT
23-06-23	ConforMIS Agrees to be Acquired by restor3d	MT

23-05-09	Oppenheimer Downgrades ConforMIS to Perform From Outperform, Removes $6 Price Target	MT
22-11-11	Oppenheimer Adjusts ConforMIS Price Target to $8 From $1.25, Maintains Outperform Rating	MT

23-09-05	Restor3d Completes Acquisition of Conformis	AQ
23-09-05	Conformis : Termination of Material Agreement - Form 8-K	PU
23-08-23	Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3d	AQ
23-08-21	Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d	AQ
23-08-02	ConforMIS: Q2 Earnings Snapshot	AQ

23-06-23	USA-Les valeurs à suivre à Wall Street (actualisé)
23-03-17	Medacta: dividende maintenu, malgré le tassement du bénéfice en 2022
22-11-15	Bourse Zurich: les indices repartent à la hausse au lendemain d'un repli
22-11-15	Medacta: archivia vertenza sui brevetti negli Usa
22-11-15	Bourse Zurich: le SMI un peu plus ferme à l'approche de la mi-journée

Manager	Title	Age	Since
James Jacobus PSD	President	55	-
Kenneth Gall SEC	Corporate Secretary	-	-
Gregory Anglum TRE	Treasurer	56	-

Conformis, Inc. Stock

Stocks

CFMS

US20717E2000

Medical Equipment, Supplies & Distribution

Latest news : Conformis, Inc.

Analysts' recommendations: Conformis, Inc.

Press Releases: Conformis, Inc.

News in other languages: Conformis, Inc.

Managers and Directors: Conformis, Inc.

Latest insider transactions

Medical Devices & Implants

Company Profile

Director	Title	Age	Since
Gregory Anglum BRD	Director/Board Member	56	2023-07-04
Kenneth Gall BRD	Director/Board Member	-	2023-09-04
James Jacobus BRD	Director/Board Member	55	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
9/5/23	Brad Langdale	Issuer sale	Director	18,379	0.2333%
9/5/23	Carrie Bienkowski	Issuer sale	Director	19,909	0.2527%
9/5/23	Kenneth Fallon	Issuer sale	Chairman	20,320	0.2580%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CONFORMIS, INC.	-.--%	-.--%	-	-	17.8M
STRYKER CORPORATION	+3.54%	+3.25%	-16.74%	+13.59%	122B
SMITH & NEPHEW PLC	+1.92%	-0.96%	-2.69%	-5.12%	12.52B
GLAUKOS CORPORATION	+0.95%	-2.07%	+62.73%	+110.30%	8.93B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-6.12%	-1.94%	-49.75%	-68.94%	4.67B
DOUBLE MEDICAL TECHNOLOGY INC.	-0.21%	-2.71%	-0.62%	+35.02%	2.63B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-2.59%	-0.76%	-18.40%	-26.34%	1.63B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-3.05%	-2.46%	-26.43%	-31.81%	1.63B
ENOVIS CORPORATION	+3.72%	-0.15%	-0.48%	-57.80%	1.5B
Average	-0.20%	-1.82%	-6.55%	-3.89%	19.47B
Weighted average by Cap.	+2.78%	+2.11%	-11.74%	+13.94%